This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
07 May 2015
The version of the article initially published online on 30 March 2015 (Nat. Med. doi:10.1038/nm.3846, 2015) failed to note Michael Rossmann's affiliation or the involvement of his collaborators, and it incorrectly placed Emory University in Decatur, Georgia, when in fact it is in Atlanta. The errors have been corrected in the HTML and PDF versions of the article.
References
Ayscue, P. et al. Morb. Mortal. Wkly. Rep. 63, 903–906 (2014).
Kreuter, J.D. et al. Arch. Pathol. Lab. Med. 135 793–796 (2011).
Midgley, C.M. et al. Morb. Mortal. Wkly. Rep. 63, 798–799 (2014)
Messacar K. et al. Lancet doi:10.1016/S0140-6736(14)62457-0 (2015).
Greninger, et al. Lancet Infect. Dis. doi:10.1016/S1473-3099(15)70093-9 (2015).
Liu, Y. et al. Science 347, 71–74 (2015).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Willyard, C. An unknown enemy: Drugs sought against EV-68 as paralysis link is explored. Nat Med 21, 419–421 (2015). https://doi.org/10.1038/nm.3846
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3846